BioCryst Pharmaceuticals (NASDAQ:BCRX) Downgraded by StockNews.com to Buy
StockNews.com downgraded shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Wednesday. Other equities analysts also recently issued research reports about the stock. HC Wainwright reiterated a “buy” rating and issued a $30.00 price target on shares of BioCryst Pharmaceuticals […]
StockNews.com downgraded shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Wednesday. Other equities analysts also recently issued research reports about the stock. HC Wainwright reiterated a “buy” rating and issued a $30.00 price target on shares of BioCryst Pharmaceuticals […]
